FDA rejection

Blue neon play button icon on dark background
Biotech

FDA plans to release more CRLs as controversial policy resumes

After 14 new rejection letters were published last week following a three-month pause, the FDA today confirmed that the policy has resumed.
Darren Incorvaia Jul 14, 2026 2:50pm
arrow back backwards u-turn turn around reverse

FDA releases 14 drug rejection letters after 3-month pause

Jul 13, 2026 11:01am
pause halt pause button

FDA halts release of new drug rejection letters

Jul 8, 2026 1:33pm
reducing people on team

Shedding 60% of workforce, Replimune vows to continue operations

Apr 21, 2026 2:15am
dart board miss failure

Replimune to lay off staff after 'disappointing' second rejection

Apr 10, 2026 1:56pm
Wooden blocks with arrow and error icon Delays and disruptions stop the process critical error concept

FDA rejects Aldeyra eye disease candidate for 3rd time

Mar 17, 2026 11:12am